NuLiv Science Preclinical Study Shows AstraGin® Su...
Category : Product Related Updates 28 January 2026NuLiv Science has released results from a new preclinical study evaluating AstraGin®, its patent...
NuLiv Science has released results from a new preclinical study evaluating AstraGin®, its patent...
AskBio Inc., a gene therapy company wholly owned by Bayer AG, has received US FDA acceptance for its...
Ascletis Pharma has received FDA IND clearance to begin a Phase II study of ASC30 in type 2 diabetes...
TempraMed Technologies has strengthened its global intellectual property portfolio with a newly gran...
"As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity m...